Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.36 |
| ▸ | XPO1 | O14980 | 3/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2799572 | 0.84 | TSHR (0.34) | TSHR | |
| SCHEMBL9746345 | 0.84 | TSHR (0.39) | TSHRLMNAADRA1APDE4DXPO1 | |
| SCHEMBL20162488 | 0.84 | TSHR (0.46) | TSHRLMNAHCAR2SMN1; SMN2ALDH1A1 | |
| SCHEMBL8621634 | 0.83 | TSHR (0.32) | TSHRALDH1A1 | |
| SCHEMBL3476792 | 0.82 | LMNA (0.44) | TSHRLMNAADRA1APDE4DXPO1 | |
| SCHEMBL6014318 | 0.82 | TSHR (0.33) | TSHR | |
| SCHEMBL6612206 | 0.82 | TSHR (0.33) | TSHR | |
| SCHEMBL26129905 | 0.81 | TSHR (0.40) | TSHRLMNAADRA1APDE4DXPO1 | |
| SCHEMBL640114 | 0.81 | TSHR (0.40) | TSHRLMNAADRA1APDE4DXPO1 | |
| SCHEMBL16659456 | 0.80 | TSHR (0.32) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114727521-A | Shell assembly and electronic equipment | OPPO广东移动通信有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-101405304-A | Method for producing polymers in aqueous solvents | BASF SE (DE) | 2009-04-08 | — | — | CN | claimed |
| CN-101282706-A | Copolymers for cosmetic applications | BASF SE (DE) | 2008-10-08 | — | — | CN | claimed |
| EP-4326703-A1 | MONOMERIC AND POLYMERIC COMPOSITIONS AND METHODS OF PRODUCING AND USING THE SAME | Align Technology, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| US-11879063-B2 | Binder compositions and uses thereof | KNAUF INSULATION, INC. | 2024-01-23 | — | — | US | disclosed |
| CN-117192671-A | Polarizing plate with phase difference layer | 日东电工株式会社 | 2023-12-08 | — | — | CN | disclosed |
| CN-117192672-A | Resin film, method for producing resin film, and method for producing phase difference film | 日东电工株式会社 | 2023-12-08 | — | — | CN | disclosed |
| US-20230331956-A1 | SULFIDE-CONTAINING STABILIZER SYSTEM FOR THIOL-ENE AND THIOL-YNE COMPOSITIONS | BRUNO BOCK CHEMISCHE FABRIK GMBH & CO. KG (DE) | 2023-10-19 | — | — | US | disclosed |
| WO-2023190750-A1 | POLYMER FILM-FORMING COMPOSITION AND SELECTIVE POLYMER FILM-FORMING METHOD | 日産化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-4214277-A1 | SULFIDE-CONTAINING STABILIZER SYSTEM FOR THIOL-ENE AND THIOL-YNE COMPOSITIONS | Bruno Bock GmbH (DE) | 2023-07-26 | — | — | EP | disclosed |
| CN-112771112-B | Aqueous composition | 陶氏环球技术有限责任公司 | 2023-03-21 | — | — | CN | disclosed |
| US-20060223848-A1 | Caspase inhibitors containing isoxazoline ring | LG CHEM, LTD. (KR) | 2006-10-05 | — | — | US | disclosed |
| EP-1660464-A1 | CASPASE INHIBITORS CONTAINING ISOXAZOLINE RING | LG Life Sciences Ltd. (KR) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005021516-A1 | CASPASE INHIBITORS CONTAINING ISOXAZOLINE RING | LG LIFE SCIENCES LTD. (KR) | 2005-03-10 | — | — | WO | disclosed |
| EP-1212309-B1 | CASPASE INHIBITOR | LG CHEM INVESTMENT LTD (KR) | 2004-08-18 | — | — | EP | disclosed |
| US-6747050-B1 | INHIBITING THE ACTIVITY OF CASPASES, PREVENTING INFLAMMATION AND APOPTOSIS | LG CHEM INVESTMENT LTD. (KR) | 2004-06-08 | — | — | US | disclosed |
| EP-1212309-A4 | CASPASE INHIBITOR | LG CHEM INVESTMENT LTD (KR) | 2002-11-27 | — | — | EP | disclosed |
| EP-1212309-A1 | CASPASE INHIBITOR | LG Chem Investment, Ltd. (KR) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001021600-A1 | CASPASE INHIBITOR | LG CHEM INVESTMENT LTD. (KR) | 2001-03-29 | — | — | WO | disclosed |
| US-5100762-A | Radiation-sensitive polymer and radiation-sensitive composition containing the same | MITSUBISHI DENKI KABUSHIKI KAISHA (JP) | 1992-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223848-A1 | Caspase inhibitors containing isoxazoline ring | CASP1, CASP7, CASP2 | TSHR 4742/4885LMNA 366/4885ADRA1A 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.